First, pretreatment of tumors with local radiotherapy leads to increased NKG2DL exposure, an altered TME, preferable T cells infiltration at tumor sites, and consequently better tumor control caused by NKG2D CAR-T cells, while yielding a very low radiotoxicity burden. The gene discussed is KLRK1; the disease is neoplasm.